Alanquihan, Eufracia L.
HRN: 21-33-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/18/2022
05/24/2022
IV
4.5 Grams
Q8hrs
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes